Midi Health founders meet FDA over estrogen patch shortage

3 articles · Updated · USA TODAY · May 6

The 6 May meeting comes as Midi says nearly half of 8,000 surveyed women in 49 states struggled to fill prescriptions, and one in 10 stopped treatment.
Doctors warn disrupted access could reverse gains in menopause care, with women rationing patches, switching brands or turning to gels and creams that often cost far more and lack insurance coverage.
The FDA said in April it was speaking with the five biggest manufacturers, while advocates argue production, insurer controls and rising long-term hormone therapy use are worsening shortages that began early this year.

New laws target powerful pharmacy middlemen. Will this solve the drug shortages and high costs crippling menopause care?

Menopause is now gaining legal recognition at work. What does this groundbreaking shift mean for American employers and employees?

After a 20-year warning was reversed, why was the health system so unprepared for the inevitable surge in patient demand?